Vincent De Guire

1.8k total citations
20 papers, 1.4k citations indexed

About

Vincent De Guire is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Vincent De Guire has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Physiology. Recurrent topics in Vincent De Guire's work include MicroRNA in disease regulation (9 papers), RNA Interference and Gene Delivery (4 papers) and Clinical Laboratory Practices and Quality Control (4 papers). Vincent De Guire is often cited by papers focused on MicroRNA in disease regulation (9 papers), RNA Interference and Gene Delivery (4 papers) and Clinical Laboratory Practices and Quality Control (4 papers). Vincent De Guire collaborates with scholars based in Canada, United States and France. Vincent De Guire's co-authors include Nicolas Tétreault, Gerardo Ferbeyre, Pascal Chartrand, François Major, Véronique Bourdeau, Emmanuelle Querido, Utpal K. Mukhopadhyay, Przemysław Sapieha, Catherine Ménard and Gregory J. Tsongalis and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Vincent De Guire

19 papers receiving 1.4k citations

Peers

Countries citing papers authored by Vincent De Guire

Since Specialization

Citations

This map shows the geographic impact of Vincent De Guire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent De Guire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent De Guire more than expected).

Fields of papers citing papers by Vincent De Guire

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent De Guire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent De Guire. The network helps show where Vincent De Guire may publish in the future.

Co-authorship network of co-authors of Vincent De Guire

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent De Guire. A scholar is included among the top collaborators of Vincent De Guire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent De Guire. Vincent De Guire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recommendations for the integration of standardized quality indicators for glucose point-of-care testing 2025 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Julie Shaw, (unknown), (unknown), Davor Brinc, (unknown), Christine Collier, (unknown), Angela W.S. Fung, (unknown), (unknown), Michael J. Knauer, Elie Kostantin, (unknown), Felix Leung, (unknown), Allison A. Venner, Paul S. F. Yip, Vincent De Guire	0
2	The final part of the CRESS trilogy – how to evaluate the quality of stability studies 2024 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Michael P. Cornes, Pieter Vermeersch, Ana-Maria Šimundić, Alexander Meyer, (unknown), (unknown), Seán J. Costelloe, Vincent De Guire, Rubén Gómez Rioja, Janne Cadamuro	1
3	A Short Turnaround of Clozapine Blood Level Results Within 6 hours is Essential for Effective Management of Severely Ill Persons with Treatment-Resistant Schizophrenia 2024 ·Therapeutic Drug Monitoring ·(unknown), Alain Lesage, Pierre Lalonde, Olivier Lipp, Vincent De Guire, (unknown), Georgios Schoretsanitis	6
4	Reference Interval Harmonization: Harnessing the Power of Big Data Analytics to Derive Common Reference Intervals across Populations and Testing Platforms 2023 ·Clinical Chemistry ·Mary Kathryn Bohn, Dana Bailey, Cynthia Balion, George S. Cembrowski, Christine Collier, Vincent De Guire, Victoria Higgins, Benjamin Jung, (unknown), David Seccombe, Jennifer Taher, Albert K.Y. Tsui, Allison A. Venner, Khosrow Adeli	7
5	Programmable self-regulated molecular buffers for precise sustained drug delivery 2022 ·Nature Communications ·(unknown), Rabeb Mouna Derbali, (unknown), (unknown), (unknown), (unknown), Vincent De Guire, Céline Fiset, Luc DesGroseillers, Jeanne Leblond Chain, Alexis Vallée‐Bélisle	9
6	Canadian Society of Clinical Chemists (CSCC) consensus guidance for testing, selection and quality management of SARS-CoV-2 point-of-care tests 2021 ·Clinical Biochemistry ·Jennifer Taher, Edward Randell, (unknown), Dana Bailey, Vincent De Guire, Sukhbir Kaur, Michael J. Knauer, Eleonora Petryayeva, Susan M. Poutanen, Julie Shaw, Uvaraj Uddayasankar, (unknown), Danijela Konforte	3
7	miR-106b suppresses pathological retinal angiogenesis 2020 ·Aging ·Catherine Ménard, Ariel M. Wilson, Agnieszka Dejda, Khalil Miloudi, François Binet, Sergio Crespo‐Garcia, Célia Parinot, Frédérique Pilon, Rachel Juneau, Elisabeth M. M. A. Andriessen, Gaëlle Mawambo, John Paul SanGiovanni, Vincent De Guire, Przemysław Sapieha	9
8	Pre-analytical quality indicators in laboratory medicine: Performance of laboratories participating in the IFCC working group “Laboratory Errors and Patient Safety” project 2019 ·Clinica Chimica Acta ·Laura Sciacovelli, Giuseppe Lippi, Zorica Šumarac, (unknown), Agnes Ivanov, Vincent De Guire, (unknown), Ada Aita, Andrea Padoan, Mario Plebani	36
9	MicroRNAs in graft-versus-host disease: a review of the latest data 2019 ·Bone Marrow Transplantation ·(unknown), Elie Kostantin, Gregory J. Tsongalis, Martin Guimond, Jean Roy, Vincent De Guire, Imran Ahmad	4
10	How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market. 2019 ·PubMed ·(unknown), (unknown), Elie Kostantin, Gregory J. Tsongalis, Vincent De Guire	199
11	Neuropilin-1 expression in adipose tissue macrophages protects against obesity and metabolic syndrome 2018 ·Science Immunology ·Ariel M. Wilson, Zhuo Shao, (unknown), Gaëlle Mawambo, Jean‐François Daudelin, Agnieszka Dejda, Frédérique Pilon, Natalija Popović, Salix Boulet, Célia Parinot, Malika Oubaha, Nathalie Labrecque, Vincent De Guire, Mathieu Laplante, Guillaume Lettre, Florian Sennlaub, Jean‐Sébastien Joyal, Michel Meunier, Przemysław Sapieha	43
12	miRNAs, single nucleotide polymorphisms (SNPs) and age-related macular degeneration (AMD) 2017 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·John Paul SanGiovanni, (unknown), Przemysław Sapieha, Vincent De Guire	34
13	Molecular Regulation of Cellular Senescence by MicroRNAs: Implications in Cancer and Age-Related Diseases 2017 ·International review of cell and molecular biology ·Mathieu Neault, Florence Couteau, (unknown), Vincent De Guire, Frédérick A. Mallette	14
14	Metabolomics: Perspectives on potential biomarkers in organ transplantation and immunosuppressant toxicity 2016 ·Clinical Biochemistry ·(unknown), Nicolas Tétreault, Robert Robitaille, Anne Boucher, Vincent De Guire	28
15	MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD 2016 ·Oncotarget ·Catherine Ménard, Flávio Rezende, Khalil Miloudi, Ariel M. Wilson, Nicolas Tétreault, Pierre Hardy, John Paul SanGiovanni, Vincent De Guire, Przemysław Sapieha	71
16	Neuron-Derived Semaphorin 3A Is an Early Inducer of Vascular Permeability in Diabetic Retinopathy via Neuropilin-1 2013 ·Cell Metabolism ·Agustin Cerani, Nicolas Tétreault, Catherine Ménard, (unknown), Chintan Patel, Nicholas Sitaras, (unknown), Dominique Leboeuf, Vincent De Guire, François Binet, Agnieszka Dejda, Flávio Rezende, Khalil Miloudi, Przemysław Sapieha	119
17	Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: Promises and challenges 2013 ·Clinical Biochemistry ·Vincent De Guire, Robert Robitaille, Nicolas Tétreault, R Guérin, Catherine Ménard, Nadia M. Bambace, Przemysław Sapieha	185
18	miRNAs: Their discovery, biogenesis and mechanism of action 2013 ·Clinical Biochemistry ·Nicolas Tétreault, Vincent De Guire	110
19	Designing small multiple-target artificial RNAs 2010 ·Nucleic Acids Research ·Vincent De Guire, Maxime Caron, (unknown), Catherine Ménard, Marie‐France Gaumont‐Leclerc, Pascal Chartrand, François Major, Gerardo Ferbeyre	37
20	An E2F/miR-20a Autoregulatory Feedback Loop 2006 ·Journal of Biological Chemistry ·(unknown), Vincent De Guire, Emmanuelle Querido, Utpal K. Mukhopadhyay, Véronique Bourdeau, François Major, Gerardo Ferbeyre, Pascal Chartrand	481

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact